Pain Management News

About 40% of patients in primary care have pain or illness that cannot be explained by diagnostic tests.

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.

Most health care workers, particularly physicians, had a lower mortality rate compared with the general population, an analysis published in JAMA Internal Medicine revealed.

Published results showed intraoperative use of remifentanil and sufentanil was independently associated with poor postoperative pain outcomes for patients undergoing elective surgery with general anesthesia.

Spine injections should not be given to adults with chronic back pain because they provide little or no pain relief vs. sham injections, according to new clinical practice guidelines.

NSAIDs “provide the greatest benefit and least harm” for treating acute pain in children compared with ketamine and opioids, according to findings from a systematic review and meta-analysis published in JAMA Pediatrics.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.

Pain may influence cancer survivors’ decisions to use tobacco or cannabis, according to results of a retrospective analysis.

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment.